Back to results
US 9,433,668 B2Granted
Prostate cancer vaccine
AssigneeWisconsin Alumni Research Foundation
InventorsDouglas G. McNeel, Brian M. Olson
Life of this patent
Estimating the term…
Abstract
Androgen receptor-based vaccines for eliciting an immune reaction in vivo against cells expressing androgen receptor are disclosed. The vaccines are useful in the treatment of prostate cancer. Also disclosed are methods for inducing immune reaction to androgen receptor or treating prostate cancer in a mammal, using the vaccines and pharmaceutical compositions comprising the vaccines.
Claims6
A method for treating prostate cancer in a human patient having prostate cancer, the method comprising the step of:
- administering to the human patient an effective amount of a DNA vaccine comprising a polynucleotide operatively linked to a transcriptional regulatory element,
- wherein the polynucleotide encodes a fragment of a mammalian androgen receptor consisting essentially of the ligand-binding domain of the receptor, the ligand-binding domain fragment selected from the group consisting of (i) SEQ ID NO:9, (ii) SEQ ID NO:10, (iii) SEQ ID NO:11, and (iv) SEQ ID NO:12,
- under conditions such that said prostate cancer is treated.
Dependencies are inferred from the claim text.